v3.25.4
Stockholder's Equity (Details) - USD ($)
 3 Months Ended
Dec. 10, 2025
Dec. 08, 2025
Sep. 19, 2025
Sep. 10, 2025
Jul. 17, 2025
Dec. 31, 2025
Dec. 31, 2024
Oct. 27, 2025
Sep. 30, 2025
Apr. 07, 2025
Aug. 05, 2024
Aug. 02, 2024
Apr. 29, 2023
Stockholder’s Equity [Line Items]                          
Common stock authorized           400,000,000     400,000,000   110,000,000    
Common stock par value (in Dollars per share)           $ 0.0001     $ 0.0001        
Preferred stock authorized           10,000,000     10,000,000        
Preferred stock par value (in Dollars per share)           $ 0.0001     $ 0.0001        
Net proceeds (in Dollars)         $ 7,546,988                
Expenses of placement agent fee (in Dollars)         $ 125,000                
Aggregate shares of common stock           91,836,387              
Common stock reserved           46,836,387              
Warrants [Member]                          
Stockholder’s Equity [Line Items]                          
Term of exercisable warrants         5 years                
Exercise price per share (in Dollars per share)         $ 1.32                
Warrant commencement date         Jan. 17, 2026                
Weighted average period           3 years 5 months 8 days              
Common stock reserved           46,836,387              
Warrants outstanding (in Dollars)           $ 15,227,835              
Placement Agent Warrants [Member]                          
Stockholder’s Equity [Line Items]                          
Warrants purchase         272,727 1,816,513              
Exercise price per share (in Dollars per share)         $ 1.65                
Fair value of the warrants (in Dollars)         $ 905,000                
Warrant expire date         Jul. 17, 2030                
Percentage of placement agent cash fee         7.00%                
Pre-Funded Warrants [Member]                          
Stockholder’s Equity [Line Items]                          
Warrants purchase 15,229,358                        
Exercise price per share (in Dollars per share) $ 1.0899                        
2024 Plan [Member]                          
Stockholder’s Equity [Line Items]                          
Aggregate shares of common stock               30,000,000          
Additional shares of common stock               15,000,000          
Common Stock [Member]                          
Stockholder’s Equity [Line Items]                          
Common stock authorized                     100,000,000    
Common stock par value (in Dollars per share)                     $ 0.0001    
Gross proceeds offering (in Dollars)         $ 9,000,000                
Percentage of placement agent fee         7.00%                
Common Stock [Member] | Placement Agent Warrants [Member]                          
Stockholder’s Equity [Line Items]                          
Warrants purchase         477,273                
Exercise price per share (in Dollars per share)         $ 1.65                
Warrant commencement date         Aug. 17, 2025                
Warrant expire date         Jul. 17, 2030                
Preferred Stock [Member]                          
Stockholder’s Equity [Line Items]                          
Preferred stock authorized                     10,000,000    
Preferred stock par value (in Dollars per share)                     $ 0.0001    
September 2025 Offering [Member]                          
Stockholder’s Equity [Line Items]                          
Warrants purchase 5,142,858                        
Net proceeds (in Dollars)       $ 7,619,854                  
Percentage of placement agent fee       7.00%                  
Expenses of placement agent fee (in Dollars)       $ 125,000                  
Warrant commencement date       Mar. 10, 2026                  
Warrant expire date       Mar. 10, 2031                  
Common stock per share (in Dollars per share)       $ 1.75                  
Gross proceeds from offering (in Dollars)       $ 9,000,000                  
September 2025 Offering [Member] | Warrants [Member]                          
Stockholder’s Equity [Line Items]                          
Exercise price per share (in Dollars per share) $ 1.09     $ 1.84                  
Fair value of the warrants (in Dollars)   $ 4,179,000   $ 6,995,000                  
Warrant commencement date       Mar. 10, 2026                  
Warrant expire date       Mar. 10, 2031                  
September 2025 Offering [Member] | Placement Agent Warrants [Member]                          
Stockholder’s Equity [Line Items]                          
Warrants purchase       205,714                  
Exercise price per share (in Dollars per share)       $ 1.92                  
Fair value of the warrants (in Dollars)       $ 717,000                  
Warrant commencement date       Mar. 10, 2026                  
Warrant expire date       Mar. 10, 2031                  
Percentage of placement agent cash fee       7.00%                  
September 2025 Offering [Member] | Common Stock [Member]                          
Stockholder’s Equity [Line Items]                          
Shares of common stock       5,142,858                  
Warrants purchase       5,142,858                  
September 2025 Offering [Member] | Common Stock [Member] | Placement Agent Warrants [Member]                          
Stockholder’s Equity [Line Items]                          
Warrants purchase       360,000                  
Exercise price per share (in Dollars per share)       $ 2.1875                  
December 2025 Offering [Member]                          
Stockholder’s Equity [Line Items]                          
Warrants purchase 16,513,762                        
Exercise price per share (in Dollars per share) $ 1.09                        
Net proceeds (in Dollars) $ 15,125,489                        
Percentage of placement agent fee 7.00%                        
Expenses of placement agent fee (in Dollars) $ 135,000                        
Gross proceeds from offering (in Dollars) $ 18,000,000                        
December 2025 Offering [Member] | Warrants [Member]                          
Stockholder’s Equity [Line Items]                          
Term of exercisable warrants 5 years                        
Warrant expire date Dec. 08, 2030                        
December 2025 Offering [Member] | Placement Agent Warrants [Member]                          
Stockholder’s Equity [Line Items]                          
Warrants purchase 1,155,963                        
Fair value of the warrants (in Dollars) $ 1,401,000                        
Warrant expire date Dec. 08, 2030                        
Percentage of placement agent cash fee 7.00%                        
December 2025 Offering [Member] | Pre-Funded Warrants [Member]                          
Stockholder’s Equity [Line Items]                          
Shares of common stock 15,229,358                        
Warrants purchase 15,229,358                        
Exercise price per share (in Dollars per share) $ 0.0001                        
Pre-funded warrants exercisable 15,229,358                        
December 2025 Offering [Member] | Investors Warrants [Member]                          
Stockholder’s Equity [Line Items]                          
Warrants purchase 16,513,762         16,513,762              
Fair value of the warrants (in Dollars) $ 13,196,000                        
December 2025 Offering [Member] | Common Stock [Member]                          
Stockholder’s Equity [Line Items]                          
Shares of common stock 1,284,404                        
Warrants purchase 1,284,404                        
Exercise price per share (in Dollars per share) $ 1.199                        
December 2025 Offering [Member] | Common Stock [Member] | Warrants [Member]                          
Stockholder’s Equity [Line Items]                          
Exercise price per share (in Dollars per share) $ 1.09                        
December 2025 Offering [Member] | Common Stock [Member] | Placement Agent Warrants [Member]                          
Stockholder’s Equity [Line Items]                          
Warrants purchase 660,550                        
Exercise price per share (in Dollars per share) $ 1.3625                        
December 2025 Offering [Member] | Common Stock [Member] | Pre-Funded Warrants [Member]                          
Stockholder’s Equity [Line Items]                          
Exercise price per share (in Dollars per share) $ 1.0899                        
Restricted Stock Award [Member]                          
Stockholder’s Equity [Line Items]                          
Stock-based compensation expense (in Dollars)           $ 1,704,015              
Restricted stock awards date     Sep. 19, 2028                    
Unrecognized total compensation cost related to unvested restricted stock awards (in Dollars)           $ 18,392,245              
Weighted average period           2 years 8 months 19 days              
Restricted Stock Award [Member] | Board of Directors [Member]                          
Stockholder’s Equity [Line Items]                          
Restricted stock awards     11,600,000                    
Restricted Stock Award [Member] | Common Stock [Member]                          
Stockholder’s Equity [Line Items]                          
Common stock on the date of grant (in Dollars)     $ 20,300,000                    
Common stock on the date of grant per share (in Dollars per share)     $ 1.75                    
Investor [Member] | Warrants [Member]                          
Stockholder’s Equity [Line Items]                          
Fair value of the warrants (in Dollars)   $ 5,301,000     $ 8,197,000                
Minimum [Member] | Common Stock [Member]                          
Stockholder’s Equity [Line Items]                          
Common stock authorized                   100,000,000      
Maximum [Member] | Common Stock [Member]                          
Stockholder’s Equity [Line Items]                          
Common stock authorized                   400,000,000      
IPO [Member] | Warrants [Member]                          
Stockholder’s Equity [Line Items]                          
Warrants purchase 6,818,182                        
Exercise price per share (in Dollars per share) $ 1.09                        
IPO [Member] | Common Stock [Member]                          
Stockholder’s Equity [Line Items]                          
Shares of common stock         6,818,182                
Warrants purchase         6,818,182                
Common stock price per share (in Dollars per share)         $ 1.32                
Stock Plans [Member]                          
Stockholder’s Equity [Line Items]                          
Aggregate shares of common stock                       15,000,000 15,000,000
Contractual term           10 years              
Stock-based compensation expense (in Dollars)           $ 2,252,035 $ 1,808,478            
Unrecognized total compensation cost (in Dollars)           $ 5,562,647              
Unrecognized total compensation cost           1 year 29 days